ATRIP and breast carcinoma: Interestingly, after publishing our results and introducing ATIRP as a novel breast cancer susceptibility gene candidate, a meta-analysis across two other large WES datasets replicated the positive association of ATRIP deleterious mutations with the risk of developing breast cancer [9].